Literature DB >> 21245444

Comparative in vitro activities of the novel antibacterial finafloxacin against selected Gram-positive and Gram-negative bacteria tested in Mueller-Hinton broth and synthetic urine.

Axel Dalhoff1, Will Stubbings, Sabine Schubert.   

Abstract

Kill kinetics and MICs of finafloxacin and ciprofloxacin against 34 strains with defined resistance mechanisms grown in cation-adjusted Mueller-Hinton broth (CAMHB) at pH values of 7.2 and 5.8 and in synthetic urine at pH 5.8 were determined. In general, finafloxacin gained activity at low pH values in CAMHB and remained almost unchanged in artificial urine. Ciprofloxacin MICs increased and bactericidal activity decreased strain dependently in acidic CAMHB and particularly in artificial urine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245444      PMCID: PMC3067158          DOI: 10.1128/AAC.00886-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis.

Authors:  J C Ojoo; S A Mulrennan; J A Kastelik; A H Morice; A E Redington
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

2.  Ascitic fluid acidosis in bacterial peritonitis: a poor prognostic sign?

Authors:  N Gitlin
Journal:  Hepatology       Date:  1990-05       Impact factor: 17.425

3.  MICs of ciprofloxacin and trimethoprim for Escherichia coli: influence of pH, inoculum size and various body fluids.

Authors:  J Aagaard; T Gasser; P Rhodes; P O Madsen
Journal:  Infection       Date:  1991       Impact factor: 3.553

4.  Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease.

Authors:  Z Borrill; C Starkey; J Vestbo; D Singh
Journal:  Eur Respir J       Date:  2005-02       Impact factor: 16.671

5.  Effect of the pH and osmolality of urine on the antibacterial activity of gentamicin.

Authors:  M Papapetropoulou; J Papavassiliou; N J Legakis
Journal:  J Antimicrob Chemother       Date:  1983-12       Impact factor: 5.790

6.  Biofilms on indwelling urethral catheters produce quorum-sensing signal molecules in situ and in vitro.

Authors:  D J Stickler; N S Morris; R J McLean; C Fuqua
Journal:  Appl Environ Microbiol       Date:  1998-09       Impact factor: 4.792

7.  Azlocillin: a new broad spectrum penicillin.

Authors:  C C Sanders
Journal:  J Antimicrob Chemother       Date:  1983-05       Impact factor: 5.790

8.  Effects of CO2 and pH on inhibition of TEM-1 and other beta-lactamases by penicillanic acid sulfones.

Authors:  D M Livermore; J E Corkill
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

9.  Impact of pH and cationic supplementation on in vitro postantibiotic effect.

Authors:  A Gudmundsson; H Erlendsdottir; M Gottfredsson; S Gudmundsson
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

10.  Effects of betaines and urine on the antibacterial activity of aminoglycosides.

Authors:  B A Peddie; S T Chambers
Journal:  J Antimicrob Chemother       Date:  1993-04       Impact factor: 5.790

View more
  12 in total

1.  Human pharmacokinetics and safety profile of finafloxacin, a new fluoroquinolone antibiotic, in healthy volunteers.

Authors:  Heena Patel; Arne Andresen; Andreas Vente; Hans-Dietrich Heilmann; Will Stubbings; Michael Seiberling; Luis Lopez-Lazaro; Rolf Pokorny; Harald Labischinski
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

2.  In vitro spectrum of activity of finafloxacin, a novel, pH-activated fluoroquinolone, under standard and acidic conditions.

Authors:  Will Stubbings; Pamela Leow; Goh Chee Yong; Falicia Goh; Barbara Körber-Irrgang; Michael Kresken; Rainer Endermann; Harald Labischinski
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

3.  Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Enterobacteriaceae.

Authors:  Maria Loose; Isabell Link; Kurt G Naber; Florian M E Wagenlehner
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

Review 4.  Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.

Authors:  Axel Dalhoff
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 5.  Finafloxacin: first global approval.

Authors:  Kate McKeage
Journal:  Drugs       Date:  2015-04       Impact factor: 9.546

6.  Explorative Randomized Phase II Clinical Study of the Efficacy and Safety of Finafloxacin versus Ciprofloxacin for Treatment of Complicated Urinary Tract Infections.

Authors:  F Wagenlehner; M Nowicki; C Bentley; M Lückermann; S Wohlert; C Fischer; A Vente; K Naber; A Dalhoff
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

7.  An IMS/ATP Assay for the Detection of Mycobacterium tuberculosis in Urine.

Authors:  Dawn M Hunter; Daniel V Lim
Journal:  Tuberc Res Treat       Date:  2012-05-09

Review 8.  The Basics of Bacteriuria: Strategies of Microbes for Persistence in Urine.

Authors:  Deepak S Ipe; Ella Horton; Glen C Ulett
Journal:  Front Cell Infect Microbiol       Date:  2016-02-08       Impact factor: 5.293

9.  Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.

Authors:  A Dalhoff; S Schubert; A Vente
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 10.  Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin.

Authors:  Bela Kocsis; J Domokos; D Szabo
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-05-23       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.